Trinity Biotech Regains Nasdaq Compliance
Ticker: TRIB · Form: 6-K · Filed: Sep 2, 2025 · CIK: 888721
| Field | Detail |
|---|---|
| Company | Trinity Biotech PLC (TRIB) |
| Form Type | 6-K |
| Filed Date | Sep 2, 2025 |
| Risk Level | low |
| Pages | 1 |
| Reading Time | 1 min |
| Sentiment | bullish |
Sentiment: bullish
Topics: compliance, listing, sec-filing
TL;DR
Trinity Biotech back above $1 on Nasdaq, dodged delisting.
AI Summary
On September 2, 2025, Trinity Biotech PLC announced it had regained compliance with the Nasdaq Stock Market's minimum bid price requirement. The company's ordinary shares had a closing bid price of $1.00 or more for a minimum of 10 consecutive business days, ending on August 29, 2025. This filing is incorporated by reference into several of Trinity Biotech's Form S-8 registration statements.
Why It Matters
Regaining compliance with Nasdaq's minimum bid price requirement is crucial for Trinity Biotech to maintain its listing on the exchange, avoiding potential delisting and ensuring continued investor confidence.
Risk Assessment
Risk Level: low — The filing confirms compliance with a standard exchange requirement, indicating a resolution of a previously identified risk.
Key Numbers
- $1.00 — Minimum Bid Price (The closing bid price requirement to regain Nasdaq compliance.)
Key Players & Entities
- Trinity Biotech PLC (company) — Registrant
- Nasdaq Stock Market (company) — Exchange where compliance was regained
- August 29, 2025 (date) — Date compliance was met
- $1.00 (dollar_amount) — Minimum bid price requirement
FAQ
What is the specific date Trinity Biotech PLC regained compliance with the Nasdaq minimum bid price requirement?
Trinity Biotech PLC regained compliance as of August 29, 2025, with the closing bid price being $1.00 or more for at least 10 consecutive business days.
What is the significance of regaining compliance with the Nasdaq minimum bid price requirement?
Regaining compliance ensures that Trinity Biotech PLC's ordinary shares continue to be listed on the Nasdaq Stock Market, preventing potential delisting.
Which Nasdaq rule did Trinity Biotech PLC comply with?
Trinity Biotech PLC complied with the Nasdaq Stock Market's minimum bid price requirement.
What is the filing type and date?
This is a Form 6-K filed on September 2, 2025.
How is this Form 6-K being used in relation to other filings?
This Form 6-K is being incorporated by reference into Trinity Biotech PLC's Registration Statements on Form S-8 (File Nos. 333-182279, 333-195232 and 333-253070).
Filing Stats: 198 words · 1 min read · ~1 pages · Grade level 10.7 · Accepted 2025-09-02 14:17:49
Filing Documents
- zk2533746.htm (6-K) — 12KB
- exhibit_99-1.htm (EX-99.1) — 12KB
- image00001.jpg (GRAPHIC) — 90KB
- 0001178913-25-003208.txt ( ) — 149KB
SIGNATURES
SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized. TRINITY BIOTECH PLC Trinity Biotech plc (Registrant) By: /s/ John Gillard John Gillard Chief Executive Officer Date: September 2, 2025